Rani Therapeutics Holdings, Inc.
NASDAQ:RANI
1.11 (USD) • At close April 30, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Assets: | ||||||
| Current Assets: | ||||||
| Cash & Cash Equivalents
| 3.762 | 5.864 | 27.007 | 117.453 | 73.058 | 16.536 |
| Short Term Investments
| 23.877 | 42.675 | 71.475 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 27.639 | 48.539 | 98.482 | 117.453 | 73.058 | 16.536 |
| Net Receivables
| 0.428 | 0 | 0 | 0 | 1.72 | 0.25 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 1.677 | 2.308 | 2.442 | 2.142 | 0.167 | 0.158 |
| Total Current Assets
| 29.744 | 50.847 | 100.924 | 119.595 | 74.945 | 16.944 |
| Non-Current Assets: | ||||||
| Property, Plant & Equipment, Net
| 6.644 | 6.823 | 7.103 | 4.612 | 4.47 | 4.453 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 1.625 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0.246 | 0.246 | 0 | 0 | 0 | 0 |
| Total Non-Current Assets
| 6.89 | 7.069 | 7.103 | 4.612 | 4.47 | 6.078 |
| Total Assets
| 36.634 | 57.916 | 108.027 | 124.207 | 79.415 | 23.022 |
| Liabilities & Equity: | ||||||
| Current Liabilities: | ||||||
| Account Payables
| 1.359 | 0.648 | 1.46 | 1.08 | 0.537 | 0.198 |
| Short Term Debt
| 16.459 | 5.615 | 2.012 | 0 | 1.359 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 1.211 | 0 | 0 | 2.717 | 0.179 |
| Other Current Liabilities
| 2.073 | 1.726 | 1.343 | 1.56 | 0.695 | 3.121 |
| Total Current Liabilities
| 19.891 | 7.989 | 4.815 | 2.64 | 5.308 | 3.498 |
| Non-Current Liabilities: | ||||||
| Long Term Debt
| 3.637 | 24.484 | 29.208 | 0 | 2.412 | 115.505 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 9.613 | 0 | 0 | 0 | 185.034 | 0.655 |
| Total Non-Current Liabilities
| 13.25 | 24.484 | 29.208 | 0 | 187.446 | 116.16 |
| Total Liabilities
| 33.141 | 32.473 | 34.023 | 2.64 | 192.754 | 119.658 |
| Equity: | ||||||
| Preferred Stock
| 0 | 0 | 0 | 124.207 | 0.185 | 0.116 |
| Common Stock
| 0.005 | 0.005 | 0.005 | 0.005 | 0.664 | 0.664 |
| Retained Earnings
| -102.907 | -72.889 | -38.919 | -8.331 | -114.003 | -97.3 |
| Accumulated Other Comprehensive Income/Loss
| 0.005 | -0.012 | -0.073 | -124.207 | -0.849 | -0.78 |
| Other Total Stockholders Equity
| 104.889 | 85.762 | 75.842 | -68.47 | 0.664 | 0.664 |
| Total Shareholders Equity
| 1.992 | 12.866 | 36.855 | 47.411 | -113.339 | -96.636 |
| Total Equity
| 3.493 | 25.443 | 74.004 | 121.567 | -113.339 | -96.636 |
| Total Liabilities & Shareholders Equity
| 36.634 | 57.916 | 108.027 | 124.207 | 79.415 | 23.022 |